Literature DB >> 33563834

Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections.

Isabella Santi1, Pablo Manfredi1, Enea Maffei1, Adrian Egli2,3, Urs Jenal4.   

Abstract

The widespread use of antibiotics promotes the evolution and dissemination of resistance and tolerance mechanisms. To assess the relevance of tolerance and its implications for resistance development, we used in vitro evolution and analyzed the inpatient microevolution of Pseudomonas aeruginosa, an important human pathogen causing acute and chronic infections. We show that the development of tolerance precedes and promotes the acquisition of resistance in vitro, and we present evidence that similar processes shape antibiotic exposure in human patients. Our data suggest that during chronic infections, P. aeruginosa first acquires moderate drug tolerance before following distinct evolutionary trajectories that lead to high-level multidrug tolerance or to antibiotic resistance. Our studies propose that the development of antibiotic tolerance predisposes bacteria for the acquisition of resistance at early stages of infection and that both mechanisms independently promote bacterial survival during antibiotic treatment at later stages of chronic infections.IMPORTANCE Over the past decades, pan-resistant strains of major bacterial pathogens have emerged and have rendered clinically available antibiotics ineffective, putting at risk many of the major achievements of modern medicine, including surgery, cancer therapy, and organ transplantation. A thorough understanding of processes leading to the development of antibiotic resistance in human patients is thus urgently needed. We show that drug tolerance, the ability of bacteria to survive prolonged exposure to bactericidal antibiotics, rapidly evolves in the opportunistic human pathogen Pseudomonas aeruginosa upon recurrent exposures to antibiotics. Our studies show that tolerance protects P. aeruginosa against different classes of antibiotics and that it generally precedes and promotes resistance development. The rapid evolution of tolerance during treatment regimens may thus act as a strong driving force to accelerate antibiotic resistance development. To successfully counter resistance, diagnostic measures and novel treatment strategies will need to incorporate the important role of antibiotic tolerance.
Copyright © 2021 Santi et al.

Entities:  

Keywords:  antibiotics; drug resistance evolution; tolerance

Year:  2021        PMID: 33563834     DOI: 10.1128/mBio.03482-20

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


  17 in total

Review 1.  Biology and evolution of bacterial toxin-antitoxin systems.

Authors:  Dukas Jurėnas; Nathan Fraikin; Frédéric Goormaghtigh; Laurence Van Melderen
Journal:  Nat Rev Microbiol       Date:  2022-01-02       Impact factor: 60.633

Review 2.  From the soil to the clinic: the impact of microbial secondary metabolites on antibiotic tolerance and resistance.

Authors:  Elena K Perry; Lucas A Meirelles; Dianne K Newman
Journal:  Nat Rev Microbiol       Date:  2021-09-16       Impact factor: 60.633

3.  The Use of Experimental Evolution to Study the Response of Pseudomonas aeruginosa to Single or Double Antibiotic Treatment.

Authors:  Isabella Santi; Pablo Manfredi; Urs Jenal
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Expanding the search for small-molecule antibacterials by multidimensional profiling.

Authors:  Karin Ortmayr; Roberto de la Cruz Moreno; Mattia Zampieri
Journal:  Nat Chem Biol       Date:  2022-05-23       Impact factor: 16.174

Review 5.  Biofilm antimicrobial susceptibility through an experimental evolutionary lens.

Authors:  Tom Coenye; Mona Bové; Thomas Bjarnsholt
Journal:  NPJ Biofilms Microbiomes       Date:  2022-10-18       Impact factor: 8.462

6.  The Quorum-Sensing Inhibitor Furanone C-30 Rapidly Loses Its Tobramycin-Potentiating Activity against Pseudomonas aeruginosa Biofilms during Experimental Evolution.

Authors:  Mona Bové; Xuerui Bao; Andrea Sass; Aurélie Crabbé; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

7.  Modulating the evolutionary trajectory of tolerance using antibiotics with different metabolic dependencies.

Authors:  Erica J Zheng; Ian W Andrews; Alexandra T Grote; Abigail L Manson; Miguel A Alcantar; Ashlee M Earl; James J Collins
Journal:  Nat Commun       Date:  2022-05-09       Impact factor: 14.919

8.  Mutations in respiratory complex I promote antibiotic persistence through alterations in intracellular acidity and protein synthesis.

Authors:  Bram Van den Bergh; Hannah Schramke; Joran Elie Michiels; Tom E P Kimkes; Jakub Leszek Radzikowski; Johannes Schimpf; Silke R Vedelaar; Sabrina Burschel; Liselot Dewachter; Nikola Lončar; Alexander Schmidt; Tim Meijer; Maarten Fauvart; Thorsten Friedrich; Jan Michiels; Matthias Heinemann
Journal:  Nat Commun       Date:  2022-01-27       Impact factor: 14.919

9.  Bugs on Drugs: A Drosophila melanogaster Gut Model to Study In Vivo Antibiotic Tolerance of E. coli.

Authors:  Bram Van den Bergh
Journal:  Microorganisms       Date:  2022-01-07

10.  The secret lives of single cells.

Authors:  Thomas K Wood
Journal:  Microb Biotechnol       Date:  2021-03-26       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.